Abstract |
The pharmacokinetics of DA-6034 in rats and dogs and first-pass effect in rats were examined. After intravenous administration, the dose-normalized AUC(0-infinity) values at 25 and 50mg/kg were significantly smaller than that at 10mg/kg. This could be due to significantly slower Cl(r) values than that at 10mg/kg, possibly due to saturated renal secretion at doses of 25 and 50mg/kg. After oral administration, the dose-normalized AUC(0-12h) values at 50 and 100mg/kg were significantly smaller than that at 25mg/kg, possibly due to poor water solubility of the drug. The low F-value (approximately 0.136%) of DA-6034 at a dose of 50mg/kg in rats could be due to considerable intestinal first-pass effect (approximately 69% of oral dose) and unabsorbed fraction from the gastrointestinal tract (approximately 30.5%). The effect of cola beverage, cimetidine, or omeprazole on the AUC(0-24h) of DA-6034 was almost negligible in rats. Pharmacokinetic parameters of DA-6034 after intravenous and oral administration at various doses were dose-independent in dogs. DA-6034 was not accumulated in rats and dogs after consecutive 7 and 28 days oral administration, respectively. The stability, blood partition, and protein binding of DA-6034 were also discussed.
|
Authors | Hye J Chung, Young H Choi, Hye D Choi, Ji M Jang, Hyun J Shim, Moohi Yoo, Jong W Kwon, Myung G Lee |
Journal | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
(Eur J Pharm Sci)
Vol. 27
Issue 4
Pg. 363-74
(Mar 2006)
ISSN: 0928-0987 [Print] Netherlands |
PMID | 16387482
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Flavonoids
- recoflavone
|
Topics |
- Administration, Oral
- Animals
- Anti-Inflammatory Agents
(administration & dosage, pharmacokinetics, therapeutic use)
- Biological Availability
- Dogs
- Drug Stability
- Erythrocytes
(metabolism)
- Flavonoids
(administration & dosage, pharmacokinetics, therapeutic use)
- In Vitro Techniques
- Inflammatory Bowel Diseases
(drug therapy)
- Injections, Intravenous
- Intestinal Absorption
- Intestine, Large
(metabolism)
- Male
- Muscles
(metabolism)
- Rats
- Rats, Sprague-Dawley
|